Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

International

●Allergic Rhinitis and its Impact on Asthma (ARIA): Care pathways for allergen immunotherapy (2019)

●International Consensus (ICON): Allergy immunotherapy II – Mechanisms, standardization, and pharmacoeconomics (2016)

●ICON: Allergy immunotherapy – Position paper (2015)

●World Allergy Organization (WAO): Statement – Allergen immunotherapy on the way to product-based evaluation (2015)

●WAO: Sublingual immunotherapy – Position paper, 2013 update (published 2014)

●WAO: Sub-lingual immunotherapy – Position paper (2009)

●WAO Taskforce: Recommendations for standardization of clinical trials with allergen specific immunotherapy for respiratory allergy – A statement (2007)

Canada

●Canadian Society of Allergy and Clinical Immunology (CSACI): Position statement on prescribing sublingual immunotherapy tables for aeroallergens (2018)

●CSACI: Consensus guidelines on practical issues of immunotherapy (2006)

United States

●American Academy of Allergy, Asthma, and Immunology (AAAAI) and American College of Allergy, Asthma, and Immunology (ACAAI): Sublingual immunotherapy – A focused allergen immunotherapy practice parameter update (2017)

●AAAAI/European Academy of Allergy and Clinical Immunology (EAACI): PRACTALL consensus report – Update on allergen immunotherapy (2013)

●AAAAI, ACAAI, and Joint Council of Allergy, Asthma, and Immunology (JCAAI): Allergen immunotherapy – A practice parameter third update (2010)

•AAAAI and ACAAI: Allergen immunotherapy – A practice parameter second update (2007)

•AAAAI and ACAAI: Allergen immunotherapy – A practice parameter (2003)

Europe

●European Academy of Allergy and Clinical Immunology (EAACI): Guidelines on allergen immunotherapy – House dust-mite driven allergic asthma (2019)

●EAACI: Guidelines on allergen immunotherapy – Allergic rhinoconjunctivitis (2018)

●EAACI: Allergen immunotherapy guidelines (2017)

●EAACI: Position paper – Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma (2017)

●EAACI: Position paper – Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis (2017)

●EAACI: Clinical contraindications to allergen immunotherapy – A position paper (2015)

●EAACI: Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis – A position paper (2014)

●American Academy of Allergy, Asthma, and Immunology (AAAAI)/EAACI: PRACTALL consensus report – Update on allergen immunotherapy (2013)

●EAACI: Perspectives on allergen-specific immunotherapy in childhood – A position statement (2012)

●EAACI: Task force report on "dose-response relationship in allergen-specific immunotherapy" (2011)

●Global Allergy and Asthma European Network (GA2LEN): The CONSORT statement checklist in allergen-specific immunotherapy (2009)

United Kingdom

●British Society for Allergy and Clinical Immunology (BSACI): Guidelines on immunotherapy for allergic rhinitis (2011)

Australia-New Zealand

●Australasian Society of Clinical Immunology and Allergy (ASCIA): Manual – Allergen immunotherapy

Japan

●[In Japanese] Japanese Society of Allergology (JSA): Guide to allergen immunotherapy in Japanese cedar pollinosis, second edition (2018)

●[In Japanese] JSA: Guide to allergen immunotherapy in mite allergy, second edition (2018)

●[In English] Guiding principles of sublingual immunotherapy for allergic rhinitis in Japanese patients (2016)

●[In English] Guiding principles of subcutaneous immunotherapy for allergic rhinitis in Japan (2014)